EGFR and breast cancer: Here, in the present study, we identified the regulation of the FoxO signaling pathway via the modulation of four genes i.e. MDM2, STAT3, IGF1R, and GRM1 which could support the functioning of the PI3K-Akt and EGFR signal against breast cancer pathogenesis.